GUD vs. THCX, CRON, TLRY, ACB, WEED, FIRE, EPI, OGI, CPH, and ICC
Should you be buying Knight Therapeutics stock or one of its competitors? The main competitors of Knight Therapeutics include Hydropothecary (THCX), Cronos Group (CRON), Tilray Brands (TLRY), Aurora Cannabis (ACB), Canopy Growth (WEED), Supreme Cannabis (FIRE), ESSA Pharma (EPI), Organigram (OGI), Cipher Pharmaceuticals (CPH), and ICC Labs (ICC). These companies are all part of the "drug manufacturers - specialty & generic" industry.
Knight Therapeutics vs. Its Competitors
Hydropothecary (CVE:THCX) and Knight Therapeutics (TSE:GUD) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, institutional ownership, analyst recommendations, risk, earnings and profitability.
12.6% of Knight Therapeutics shares are held by institutional investors. 45.6% of Knight Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
In the previous week, Hydropothecary's average media sentiment score of 0.00 equaled Knight Therapeutics'average media sentiment score.
Hydropothecary has higher earnings, but lower revenue than Knight Therapeutics.
Hydropothecary has a net margin of 0.00% compared to Knight Therapeutics' net margin of -8.81%. Hydropothecary's return on equity of 0.00% beat Knight Therapeutics' return on equity.
Knight Therapeutics has a consensus price target of C$7.15, suggesting a potential upside of 18.38%. Given Knight Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Knight Therapeutics is more favorable than Hydropothecary.
Summary
Knight Therapeutics beats Hydropothecary on 8 of the 10 factors compared between the two stocks.
Get Knight Therapeutics News Delivered to You Automatically
Sign up to receive the latest news and ratings for GUD and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding GUD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Knight Therapeutics Competitors List
Related Companies and Tools
This page (TSE:GUD) was last updated on 7/4/2025 by MarketBeat.com Staff
Free GUD Stock Alerts